Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Lleida
Clinical trial register · Spain

Clinical Trials in Lleida, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Lleida

118 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
PainTrain-AI Implementation Trial in Primary Care (Competency Gaps and Gender Bias)
NCT07507019Educational Intervention for Primary Care Professionals on Chronic Musculoskeletal Pain
Francesc Valenzuela Pascual
Not applicable
185
Lleida
2029-03
Not yet open
Francesc Valenzuela Pascual
Not applicable
40
Lleida
2027-01
Recruiting
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
NCT07559175Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality, Pancreatic Diseases
DrugZenpep
Aimmune Nestlé Health Science US R&D, LLC
Phase 2
66
Madrid, Murcia, Lleida, Málaga, Valencia
2026-10
Recruiting
AstraZeneca
Phase 3
1,500
A Coruña, Alzira, Barcelona, Ferrol, Lleida, Málaga, Oviedo, Segovia
2026-08-20
Recruiting
AstraZeneca
Phase 3
900
Barcelona, Ferrol, Lleida, Madrid, Majadahonda, Málaga, Santander, Seville
2026-07-06
Recruiting
Rovi Pharmaceuticals Laboratories
Phase 1
120
Alcorcón, Barcelona, Granada, Jaén, León, Lleida, Manresa, Málaga
2026-06-08
Active, closed
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Phase 4
225
Lleida
2026-06-01
Not yet open
Universitat de Lleida
Observational
300
Lleida
2026-06
Recruiting
Novo Nordisk A/S
Phase 3
300
Guadalajara, Pozuelo de Alarcón, Barcelona, Castilleja de la Cuesta, Lleida, Logroño, Madrid, Vitoria-Gasteiz
2026-05-05
Recruiting
Novo Nordisk A/S
Phase 3
300
Guadalajara, Pozuelo de Alarcón, Barcelona, Castilleja de la Cuesta, Lleida, Logroño, Madrid, Vitoria-Gasteiz
2026-05-05
Active, closed
Hospital Arnau de Vilanova
Not applicable
62
Lleida
2026-04-20
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
150
Barcelona, Córdoba, Lleida, Madrid, Ourense, Sant Cugat del Vallès
2026-04-16
Not yet open
Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI
NCT07529015Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI) Amnestic, Cognitively Unimpaired
Institut de Recerca Biomèdica de Lleida-Fundació Dr. Pifarré (IRBLleida)
Not applicable
114
Lleida
2026-04
Recruiting
Hoffmann-La Roche
Phase 2
360
L'Hospitalet de Llobregat, Salt, Santiago de Compostela, Lleida, Pozuelo de Alarcón, El Palmar, Vigo, Barakaldo
2026-03-10
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Barcelona, Lleida, Palma de Mallorca
2026-03-01
Not yet open
GEL-AID: Safe and Effective Hydration for Institutionalized Older Adults
NCT07381881Dehydration, Urinary Infections, Respiratory Infections, Daily Fluid Intake
Universitat de Lleida
Not applicable
156
Lleida
2026-02-23
Recruiting
Eli Lilly and Company
Phase 3
800
Guadalajara, Lleida, Logroño, Madrid, Málaga, Seville
2026-02-10
Not yet open
Universitat de Lleida
Not applicable
24
Lleida
2026-02-09
Recruiting
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Observational
1,500
Leganés, Barcelona, Lleida, Madrid, Murcia, Pamplona, Salamanca, Santiago de Compostela
2026-01-13
Recruiting
Inhaled Sedation in Critically Ill Patients
NCT07000526Sedation, Airway Extubation
Instituto de Investigación Hospital Universitario La Paz
Phase 4
620
Orihuela, Arrecife, Galdakao, Albacete, Badalona, Barcelona, Jaén, Lleida
2025-12-15
Recruiting
ALX Oncology Inc.
Phase 2
120
Málaga, Seville, Bilbao, Barcelona, Lleida, Madrid
2025-12-10
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Alicante, Barcelona, Granada, León, Lleida, Madrid, Murcia, Seville
2025-11-03
Recruiting
GlaxoSmithKline
Phase 2
363
Barcelona, Lleida, Madrid, MErida Badajoz, Oviedo, Valencia
2025-10-30
Recruiting
Comprehensive Maintenance Program: a Health Haven for COPD in Lleida.The NAPOLEON Project.
NCT07394712COPD - Chronic Obstructive Pulmonary Disease, Pulmonary Rehabilitation, Randomised Controlled Trial
Institut de Recerca Biomèdica de Lleida
Not applicable
86
Lleida
2025-10-01
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Sant Cugat del Vallès, Terrassa, Donostia / San Sebastian, Lleida, Pozuelo de Alarcón, Barcelona, Córdoba, Madrid
2025-09-17
Recruiting
Celcuity Inc
Phase 3
1,180
A Coruña, Badajoz, Barcelona, Cáceres, El Palmar, L'Hospitalet de Llobregat, Lleida, Madrid
2025-07-24
Recruiting
Bristol-Myers Squibb
Phase 3
586
Seville, Sant Cugat del Vallès, Barcelona, Lleida, Pamplona, Madrid
2025-07-14
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
A Coruña, Barcelona, Bilbao, El Palmar, Huelva, Jaén, L'Hospitalet de Llobregat, Lleida
2025-07-02
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Córdoba, Málaga, Las Palmas de Gran Canaria, Badalona, Barcelona, L'Hospitalet de Llobregat, Lleida, A Coruña
2025-06-25
Recruiting
Chronic Insomnia in Non-Cancer Pain Patients
NCT07057232Chronic Non-cancer Pain, Insomnia
Germans Trias i Pujol Hospital
Observational
385
Badalona, Barcelona, Girona, Hospitalet Del Llobregat, Lleida, Sant Joan Despí, Tarragona, Terrassa
2025-06-09
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
500
Elche, San Cugat Del Valles Barcelona, Madrid, Navarra, A Coruña, Barcelona, El Palmar, Lleida
2025-05-22
Recruiting
Joseph Broderick, MD
Phase 3
350
Badalona, Horta, L'Hospitalet de Llobregat, Barcelona, Girona, Lleida, Valladolid
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Alicante, Barcelona, Girona, Lleida, Madrid, Palma de Mallorca, Tarragona, Valencia
2025-05-05
Recruiting
Parc de Salut Mar
Observational
505
Badalona, Barcelona, L'Hospitalet de Llobregat, Puerto Real, Logroño, Lleida
2025-05-03
Recruiting
Protocol to Improve the Representation of the Reproductive Process in Spanish Fiction.
NCT06842004Sexual Health, Community Participation, Social Norms
Universitat de Lleida
Not applicable
60
Lleida
2025-04-01
Recruiting
University of Vic - Central University of Catalonia
Not applicable
120
Lleida, Vic
2025-03-24
Active, closed
Efficacy of a Dog Assisted Group Intervention in Elderly with Unwanted Loneliness
NCT06860412Loneliness, Elderly (people Aged 65 or More), Animal Assisted Therapy
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Not applicable
20
Lleida
2025-02-12
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Barcelona, Lleida, Madrid, Málaga, Valencia
2025-02-07
Recruiting
Airway Therapeutics, Inc.
Phase 2/3
366
Alicante, Barcelona, Bilbao, Cadiz, Lleida, Madrid, Málaga, Santiago de Compostela
2025-02-03
Recruiting
Probelte Pharma S.L.U.
Observational
27
Barcelona, Castellon, Ciudad Real, Córdoba, Girona, Lleida, Madrid, Orihuela
2025-02-01
Recruiting
BioNTech SE
Phase 2/3
1,580
A Coruña, Badajoz, Badalona, Barcelona, Castellon, Las Palmas de Gran Canaria, León, Lleida
2025-01-07
Recruiting
UNICANCER
Phase 2
354
Alicante, Badalona, Barcelona, El Palmar, Granada, L'Hospitalet de Llobregat, León, Lleida
2024-12-27
Active, closed
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Phase 2
28
Palma de Mallorca, Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Lleida, Tarragona, Terrassa
2024-12-16
Recruiting
AstraZeneca
Phase 3
1,160
Barcelona, Las Palmas de Gran Canaria, Lleida, Madrid, Majadahonda, Seville
2024-11-18
Active, closed
Amgen
Phase 2
409
Castilleja de la Cuesta, Málaga, Lleida, A Coruña, Alzira
2024-11-07
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
NCT06625775Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1
392
Barcelona, Madrid, Pozuelo de Alarcón, Lleida, Valencia
2024-10-29
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Majadahonda, Málaga, Lleida, Madrid, Salamanca, Seville, Valladolid, Zaragoza
2024-09-26
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Barcelona, Córdoba, Lleida, Madrid, Pamplona, Santiago de Compostela, Seville, Valencia
2024-08-30
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Santiago Compostela, L'Hospitalet de Llobregat, Alicante, Barcelona, Lleida, Madrid, Málaga, Valencia
2024-07-31
Recruiting
NovoCure GmbH
Phase 3
734
Elche, Seville, Barcelona, Torrejón de Ardoz, Lleida, Madrid, Málaga, Pamplona
2024-07-31
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Barcelona, Getxo, Lleida, Madrid, Pamplona, Pozuelo de Alarcón, Sant Cugat del Vallès, Terrassa
2024-07-22
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Ferrol, Lleida, Madrid, Majadahonda, Seville, Valencia
2024-07-18
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Badalona, Málaga, El Palmar, A Coruña, Alicante, Barcelona, Lleida, Madrid
2024-06-25
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Albacete, Barcelona, Las Palmas de Gran Canaria, Lleida, Madrid, Marbella, Oviedo, Salamanca
2024-06-07
Recruiting
CSL Behring
Phase 2/3
3,110
Alcobendas, Barcelona, Córdoba, Girona, Granada, Guadalajara, Lleida, Madrid
2024-04-27
Active, closed
argenx
Phase 3
119
Alicante, Barcelona, Lleida, Madrid, Santiago de Compostela, Valencia
2024-04-16
Recruiting
Sociedad Española de Neumología y Cirugía Torácica
Observational
1,523
Lleida
2024-04-16
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
Alexion Pharmaceuticals, Inc.
Phase 3
584
A Coruña, Alcalá de Henares, Lleida, Madrid, Málaga, Murcia, Oviedo, Seville
2024-03-29
Active, closed
Bristol-Myers Squibb
Phase 2
310
Barcelona, Sant Cugat del Vallès, Lleida
2024-03-20
Recruiting
Genetic Susceptibility to Predict Weight Loss After Bariatric Surgery
NCT06226194Bariatric Surgery Candidate, Obesity, Morbid, Genetic Predisposition, Metabolic Syndrome
Institut de Recerca Biomèdica de Lleida
Observational
6,966
Lleida
2024-03-15
Active, closed
Pfizer
Phase 1/2
71
Barcelona, Lleida, Madrid, Seville
2024-02-19
Recruiting
Hospital Arnau de Vilanova
Not applicable
146
Lleida
2024-02-01
Active, closed
Sanofi
Phase 3
943
Murcia, Barcelona, Barakaldo, L'Hospitalet de Llobregat, Donostia / San Sebastian, Girona, Las Palmas de Gran Canaria, Lleida
2023-12-27
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Alicante, Barakaldo, El Palmar, Girona, Granada, L'Hospitalet de Llobregat, Lleida, Madrid
2023-12-15
Active, closed
AnaptysBio, Inc.
Phase 2
132
Alicante, Lleida
2023-12-04
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Pharmaceuticals, Inc.
Phase 3
510
Badajoz, Badalona, Manresa, Girona, León, Lleida, Madrid, Pamplona
2023-11-16
Recruiting
Tallaght University Hospital
Not applicable
126
Lleida
2023-10-01
Recruiting
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171Glomerulonephritis Rapidly Progressive
Alentis Therapeutics AG
Phase 2
80
Barcelona, Lleida, Madrid, Málaga
2023-09-07
Active, closed
Hoffmann-La Roche
Phase 3
459
Lleida, Barcelona, Córdoba, Lugo, Madrid, Seville
2023-08-08
Recruiting
Oncorena AB
Phase 1/2
75
Lleida
2023-08-04
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Majadahonda, Málaga, Barcelona, Lleida, Madrid, Salamanca, Seville, Valladolid
2023-07-11
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Manises, Barcelona, Girona, Lleida, Lugo, Madrid, Seville
2023-07-06
Recruiting
Institut de Recerca Biomèdica de Lleida
Observational
246
Tortosa, Lleida, Tarragona
2023-06-29
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
A Coruña, Alicante, Barcelona, El Palmar, Lleida, Madrid, Manises, Málaga
2023-04-11
Active, closed
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
NCT05650879HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation, HER2 Amplification
Enliven Therapeutics
Phase 1
198
Lleida, Seville, Barcelona, L'Hospitalet de Llobregat, Madrid, Valencia
2023-03-20
Active, closed
Pfizer
Phase 3
624
A Coruña, Elche, Badalona, Barcelona, Bilbao, L'Hospitalet de Llobregat, Donostia / San Sebastian, Lleida
2023-03-03
Active, closed
Daiichi Sankyo
Phase 3
1,170
Barcelona, Lleida, Madrid, Málaga, Ourense, Seville, Valenica, Zaragoza
2023-01-11
Recruiting
GBG Forschungs GmbH
Phase 2
170
Barcelona, Granada, Lleida, Madrid, Murcia, Palma de Mallorca, Santander, Seville
2023-01-02
Recruiting
Taiho Oncology, Inc.
Phase 1
27
Barcelona, La Rioja, Lleida, Madrid, Murcia, Valencia
2022-12-23
Recruiting
The Impact of Radiotherapy on Oligometastatic Cancer
NCT05933876Metastasis, Metastatic Breast Cancer, Metastatic Prostate Cancer, Metastatic Colorectal Cancer
Institut Investigacio Sanitaria Pere Virgili
Observational
2,000
Albacete, Barcelona, Granada, Lleida, Madrid, Seville, Reus, Valencia
2022-12-01
Active, closed
University Medical Center Groningen
Phase 3
1,750
Barcelona, Lleida, Madrid, Palma de Mallorca, Pamplona, Valencia
2022-11-08
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
L'Hospitalet de Llobregat, Barcelona, San Cristóbal de La Laguna, Alicante, Córdoba, Lleida, Madrid, Málaga
2022-10-24
Recruiting
GBG Forschungs GmbH
Observational
400
Córdoba, Bilbao, Santa Cruz de Tenerife, Badalona, Barcelona, Lleida, Sabadell, Cáceres
2022-10-12
Active, closed
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases
Eli Lilly and Company
Phase 3
1,500
Barcelona, Lleida, Sant Cugat del Vallès, Valencia
2022-10-10
Active, closed
AbbVie
Phase 2
125
A Coruña, Badalona, Córdoba, Pamplona, Badajoz, Barcelona, Lleida, Madrid
2022-09-28
Active, closed
Exelixis
Phase 3
901
Barcelona, Lleida, Madrid, Valencia, Zaragoza
2022-09-07
Active, closed
Biogen
Phase 2
416
Pamplona, Getxo, Barcelona, Córdoba, Lleida, Seville, Valencia
2022-08-24
Active, closed
Gilead Sciences
Phase 3
443
A Coruña, Barcelona, Bilbao, Lleida, Madrid, Málaga, Murcia, Santa Cruz de Tenerife
2022-07-25
Active, closed
Gilead Sciences
Phase 3
623
A Coruña, Barcelona, Bilbao, Lleida, Madrid, Murcia, Seville, Valencia
2022-07-20
Recruiting
Pfizer
Phase 4
210
A Coruña, Badalona, Barcelona, Santander, Lleida, Majadahonda, Madrid, Málaga
2022-07-05
Recruiting
Telios Pharma, Inc.
Phase 1/2
70
Lleida, Madrid, Málaga, Zaragoza
2022-06-09
Active, closed
Daiichi Sankyo
Phase 3
740
Barcelona, Lleida, Madrid, Málaga, Ourense, Seville, Valencia, Zaragoza
2022-03-04
Recruiting
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Not applicable
120
Lleida
2022-01-01
Recruiting
Taiho Oncology, Inc.
Phase 1
18
Barcelona, La Rioja, Lleida, Madrid, Murcia, Valencia
2021-12-15
Active, closed
Joseph Broderick, MD
Phase 3
860
Badalona, Horta, L'Hospitalet de Llobregat, Barcelona, Girona, Lleida
2021-12-03
Active, closed
Eli Lilly and Company
Phase 3
874
Barcelona, Cáceres, Lleida, Madrid, San Cristóbal de La Laguna, Valencia, Granada, Seville
2021-10-04
Active, closed
AstraZeneca
Phase 3
893
Barcelona, Granada, Lleida, Madrid, Málaga, Pamplona, Santiago de Compostela
2021-05-10
Recruiting
Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics
NCT05761080Laparoscopic Appendectomy, Complicated Appendicitis, Periappendicular Abscess
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 4
772
Barcelona, Córdoba, Lleida, Madrid, Seville, Badalona, Esplugues de Llobregat, Girona
2021-04-22
Active, closed
AstraZeneca
Phase 3
1,371
Barcelona, Jaén, Lleida, Madrid, Málaga, Pamplona, Santander, Seville
2021-01-28
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT04657068Advanced Cancer, Metastatic Cancer, Ovarian Cancer, Primary Peritoneal Cancer
Artios Pharma Ltd
Phase 1/2
542
Elche, Sabadell, Santander, Barcelona, Lleida, Madrid, Pozuelo de Alarcón, El Palmar
2021-01-27
Active, closed
Genmab
Phase 3
483
Badalona, Barcelona, Cadiz, Cáceres, Córdoba, Lleida, Madrid, Salamanca
2021-01-13
Recruiting
Integrative Diagnosis for SCD and Other RADs
NCT07206095Sickle Cell Disease, Thalassaemia, Congenital Dyserythropoietic Anemia (CDA), Enzyme Disorder; Anemia
Hospital Universitari Vall d'Hebron Research Institute
Observational
200
Barcelona, Esplugues de Llobregat, Granollers, Mataró, Sabadell, Terrassa, Lleida
2020-11-13
Active, closed
Hoffmann-La Roche
Phase 3
985
A Coruña, Lleida, Pozuelo de Alarcón, Vigo, Barcelona, Cadiz, Madrid, Málaga
2020-10-26
Recruiting
Pancreatic Cancer Early Detection Consortium
NCT04970056Pancreas Cancer, Pancreas Cyst, Pancreatic Ductal Adenocarcinoma, Genetic Predisposition
Arbor Research Collaborative for Health
Observational
20,000
Barcelona, Lleida, Madrid
2020-09-18
Active, closed
AstraZeneca
Phase 3
818
A Coruña, Barcelona, Córdoba, Hosp de Llobregat(Barcelona), Jaén, La Laguna (Tenerife), Lleida, Madrid
2020-04-16
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Barcelona, Girona, Lleida, Madrid, Palma, Tarragona, Valencia
2019-12-20
Active, closed
SOLTI Breast Cancer Research Group
Not applicable
180
Badalona, Barcelona, Jerez de la Frontera, Santa Cruz de Tenerife, Lleida, Madrid, Seville, Valencia
2019-12-13
By invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
NCT04093570Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
Taiho Oncology, Inc.
Phase 2
332
Lleida, Madrid, Murcia, Valencia
2019-09-30
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
366
Barcelona, Lleida, Madrid, Reus, Seville, Valencia
2019-06-14
Recruiting
Normotensive OSA Patients With Dipper Circadian Blood Pressure Pattern
NCT03948373Normotensive, Sleep Apnea, Obstructive
Sociedad Española de Neumología y Cirugía Torácica
Not applicable
64
Lleida
2019-05-07
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 2
393
Llobregat, Pamplona, Barcelona, Cáceres, Córdoba, Lleida, Madrid, Málaga
2019-03-15
Active, closed
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,167
Barcelona, Lleida, Seville
2017-08-21
Active, closed
Eli Lilly and Company
Phase 3
5,637
Córdoba, Barcelona, Santiago de Compostela, Lleida, Pozuelo de Alarcón, Alcorcón, Madrid, Málaga
2017-07-12
Active, closed
The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease
NCT03228459Atherosclerosis, Chronic Kidney Diseases, Metabolic Syndrome, PreDiabetes
Institut de Recerca Biomèdica de Lleida
Not applicable
16,660
Lleida
2015-01-15
Active, closed
Eli Lilly and Company
Phase 3
493
Badajoz, Barcelona, Donostia / San Sebastian, Lleida, Madrid, Valencia
2014-11-06
Active, closed
Eli Lilly and Company
Phase 3
669
Elche, Barcelona, Lleida, Madrid, Murcia, Valencia
2014-07-22
Recruiting
Jules Bordet Institute
Not applicable
1,000
A Coruña, Barcelona, Castellon, Cáceres, Lleida, Madrid, Seville, Valencia
2014-04
Active, closed
Genentech, Inc.
Phase 2
378
Elche, Jerez de la Frontera, Donostia / San Sebastian, Barcelona, Cáceres, Lleida, Madrid, Zaragoza
2008-10-16
Rows per page Showing 1–118 of 118
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/lleida

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 118 of those studies with a site in Lleida.

How many clinical trials are recruiting in Lleida?

61 of the 118 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 6 have not yet opened recruitment, 50 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lleida), 118 studies
PhaseStudiesRecruitingShare
Phase 3532144.9%
Phase 219816.1%
Not applicable18815.3%
Observational121110.2%
Phase 1544.2%
Phase 1/2433.4%
Phase 4433.4%
Phase 2/3332.5%

Most active sponsors

Lead sponsors with the most studies (Lleida)
Lead sponsorStudiesRecruiting
AstraZeneca63
Eli Lilly and Company61
Hoffmann-La Roche41
Institut de Recerca Biomèdica de Lleida43
Universitat de Lleida41
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina31
Novartis Pharmaceuticals30
Novo Nordisk A/S32
Pfizer31
Stichting Hemato-Oncologie voor Volwassenen Nederland32
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.